• Symposium | The next wave of immune-based therapies: What you need to know in relapsed/refractory multiple myeloma

  • Aug 13 2024
  • Duración: 25 m
  • Podcast

Symposium | The next wave of immune-based therapies: What you need to know in relapsed/refractory multiple myeloma

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint satellite symposium entitled ‘Sequencing immune-based therapies in B-cell malignancies’.

    Here the Multiple Myeloma Hub is pleased to share the session: Next wave of immune-based therapies: What you need to know, which focused on relapsed/refractory (R/R) multiple myeloma (MM) and was presented by Krina Patel, MD Anderson Cancer Center, Houston, US.



    This activity was supported through an educational grant from Bristol Myers Squibb.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Symposium | The next wave of immune-based therapies: What you need to know in relapsed/refractory multiple myeloma

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles